TY - JOUR
T1 - Association of maternal lipid profile and gestational diabetes mellitus: A systematic review and meta-analysis of 292 studies and 97,880 women
AU - Hu, Jiamiao
AU - Gillies, Clare L.
AU - Lin, Shaoling
AU - Stewart, Zoe A.
AU - Melford, Sarah E.
AU - Abrams, Keith R.
AU - Baker, Philip N.
AU - Khunti, Kamlesh
AU - Tan, Bee Kang
N1 - Data sharing statement: All data used and generated in this study is available in the manuscript and supporting information.
Funding information: This study was supported by University of Leicester Global Challenge Research Fund Visiting Fellowships; Natural Science Foundation of China ( 81703065 ); the National Institute for Health Research for Applied Research Collaboration – East Midlands (NIHR ARC-EM); Leicester Biomedical Research Centre (BRC) and Medical Research Council (MRC), UK.
PY - 2021/4
Y1 - 2021/4
N2 - Background: Gestational Diabetes Mellitus (GDM) is the most prevalent metabolic disorder during pregnancy, however, the association between dyslipidaemia and GDM remains unclear. Methods: We searched Medline, Scopus, Web of Science, Cochrane, Maternity and Infant Care database (MIDIRS) and ClinicalTrials.gov up to February 2021 for relevant studies which reported on the circulating lipid profile during pregnancy, in women with and without GDM. Publications describing original data with at least one raw lipid [triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), or very low-density lipoprotein cholesterol (VLDL-C)] measurement were retained. Data extraction was performed using a piloted data extraction form. The protocol was registered with PROSPERO (CRD42019139696). Findings: A total of 292 studies, comprising of 97,880 pregnant women (28232 GDM and 69,648 controls) were included. Using random-effects meta-analysis models to pool study estimates, women with GDM had significantly higher (by 20%) TG levels, with a pooled weighted mean difference between GDM and non-GDM pregnancies of 0.388 mM (0.336, 0.439, p < 0.001). Further analyses revealed elevated TG levels occur in the first trimester and persist afterwards. Meta-regression analyses showed that differences in TG levels between women with GDM and healthy controls were significantly associated with age, BMI, study continent, OGTT procedure, and GDM diagnosis criteria. Interpretation: Elevated lipids, particularly, TG, are associated with GDM.
AB - Background: Gestational Diabetes Mellitus (GDM) is the most prevalent metabolic disorder during pregnancy, however, the association between dyslipidaemia and GDM remains unclear. Methods: We searched Medline, Scopus, Web of Science, Cochrane, Maternity and Infant Care database (MIDIRS) and ClinicalTrials.gov up to February 2021 for relevant studies which reported on the circulating lipid profile during pregnancy, in women with and without GDM. Publications describing original data with at least one raw lipid [triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), or very low-density lipoprotein cholesterol (VLDL-C)] measurement were retained. Data extraction was performed using a piloted data extraction form. The protocol was registered with PROSPERO (CRD42019139696). Findings: A total of 292 studies, comprising of 97,880 pregnant women (28232 GDM and 69,648 controls) were included. Using random-effects meta-analysis models to pool study estimates, women with GDM had significantly higher (by 20%) TG levels, with a pooled weighted mean difference between GDM and non-GDM pregnancies of 0.388 mM (0.336, 0.439, p < 0.001). Further analyses revealed elevated TG levels occur in the first trimester and persist afterwards. Meta-regression analyses showed that differences in TG levels between women with GDM and healthy controls were significantly associated with age, BMI, study continent, OGTT procedure, and GDM diagnosis criteria. Interpretation: Elevated lipids, particularly, TG, are associated with GDM.
KW - Gestational diabetes mellitus
KW - Lipids
KW - Oral glucose tolerance test
KW - Triglyceride
KW - Very low-density lipoprotein cholesterol
UR - http://www.scopus.com/inward/record.url?scp=85104363931&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2021.100830
DO - 10.1016/j.eclinm.2021.100830
M3 - Article
VL - 34
JO - eClinicalMedicine
JF - eClinicalMedicine
M1 - 100830
ER -
